Switch to:
More From Other Websites
Less than a year on from AbbVie, there's a delicious irony to Shire's $30bn bid for Baxalta Aug 04 2015
Shire in $30bn hostile approach for Baxalta Aug 04 2015
Shire/Baxalta: merry-go-round Aug 04 2015
Drugmaker Shire bids $30 billion for Baxter spin-off Baxalta Aug 04 2015
Drugmaker Shire bids $30 bln for Baxter spin-off Baxalta Aug 04 2015
Drugmaker Shire bids $30 bln for Baxter spin-off Baxalta Aug 04 2015
AbbVie, Inc. Earnings Q2*, 2015 Aug 03 2015
Highway Bill to Spend $500 Million for Veterans’ Hepatitis Drugs Jul 31 2015
NBIX: Three More Data Readouts Coming in the Second Half of 2015 - Analyst Blog Jul 30 2015
NBIX: Three More Data Readouts Coming in the Second Half of 2015… Jul 30 2015
The Zacks Analyst Blog Highlights: Biogen, AbbVie, Regeneron, Amgen and XOMA - Press Releases Jul 30 2015
HUMIRA® (Adalimumab) Approved by European Commission for Moderate to Severe Hidradenitis... Jul 30 2015
Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst... Jul 29 2015
AbbVie (ABBV) Stock Price Target Raised at Deutsche Bank Jul 29 2015
Eli Lilly & Co. Earnings Analysis: By the Numbers Jul 29 2015
Bristol-Myers Squibb Co. Earnings Analysis: By the Numbers Jul 29 2015
Gilead Lifts Sales View As Hep C Drugs Top Jul 28 2015
Gilead higher after earnings beat Jul 28 2015
Express Scripts Raises Guidance as Earnings Top Views Jul 28 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK